Holger Engelkamp, lead partner of the transaction, said:
We were able to support our client in successfully underwriting this important transaction. This sale enables our client to sharpen its strategic focus and optimally align its portfolio. With biogeen, we found a buyer whose vision for sustainable energy is perfectly aligned with SEFE Mobility’s focus.
SEFE, based in Berlin, is active along the entire energy value chain — from procurement and trading to sales, transportation and storage. With an annual sales volume of 200 terawatt-hours of gas and electricity, SEFE is one of the most important suppliers of industrial customers in Europe and supplies more than 50,000 customers, from small companies to municipal utilities and multinational corporations. SEFE employs around 2,000 people worldwide and is a federally owned company.
SEFE Mobility, based in Berlin, operates more than 50 filling stations for renewable biofuels in Germany and the Czech Republic. The company employs eight people and generated a turnover of around EUR 12 million in 2024.
biogeen is one of the leading biomethane producers in Germany and operates modern biogas plants to generate climate-friendly, regional and reliably available energy. biogeen is a portfolio company of Partners Group, one of the largest companies in the global private markets industry.
Baker McKenzie’s Corporate/M&A practice regularly advises on national and international transactions. Most recently, Baker McKenzie advised the following companies, among others: Thoma Bravo on the acquisition of Boeing’s Digital Aviation Solutions business; Trane Technologies on the acquisition of a stake in Kieback&Peter; Copeland on the acquisition of SPH Sustainable Process Heat; ResInvest on the acquisition of Onyx Power; AURELIUS on the acquisition of Landis+Gyr’s EMEA business; Knorr-Bremse on the acquisition of duagon Group; Cheyne Capital on the refinancing of Kaffee Partner; JD.com on the acquisition of Ceconomy; VINCI Energies on the acquisition of the R + S Group and the Zimmer & Hälbig Group; Bristol Myers Squibb on the transfer of Juno Therapeutics to TQ Therapeutics; Georg Fischer on the acquisition of the VAG Group; and AURELIUS on the acquisition of Teijin Automotive Technologies.
Legal adviser to SEFE:
Baker McKenzie
Lead:
Corporate/M&A: Holger Engelkamp (partner, Berlin)
Team:
Corporate/M&A: Ben Boi Beetz (associate, Berlin)
Tax: Thomas Gierath (partner), Tim Edelhoff (associate, both Munich)